Preclinical News and Research

RSS
Drug repurposing offers hope for SYNGAP1 patients

Drug repurposing offers hope for SYNGAP1 patients

Scientists discover novel compound to combat age-related blindness

Scientists discover novel compound to combat age-related blindness

Researchers uncover key mechanisms of CRISPR gene editing

Researchers uncover key mechanisms of CRISPR gene editing

C. elegans model system accelerates discovery of amyloid inhibitors

C. elegans model system accelerates discovery of amyloid inhibitors

Novel class of encrypted peptides offers hope against drug-resistant bacteria

Novel class of encrypted peptides offers hope against drug-resistant bacteria

Unlocking the secrets of Usher syndrome

Unlocking the secrets of Usher syndrome

UCLA researchers identify key protein in heart healing after attack

UCLA researchers identify key protein in heart healing after attack

RNA modifications and their role in cancer development

RNA modifications and their role in cancer development

Semaglutide may reduce Alzheimer's risk in diabetics

Semaglutide may reduce Alzheimer's risk in diabetics

Study links gut bacteria infection to Alzheimer's disease progression

Study links gut bacteria infection to Alzheimer's disease progression

Researchers develop first-of-its-kind therapy to enhance heart repair after a heart attack

Researchers develop first-of-its-kind therapy to enhance heart repair after a heart attack

UPM Biomedicals launches FibGel™ the world's first injectable nanocellulose hydrogel for medical devices

UPM Biomedicals launches FibGel™ the world's first injectable nanocellulose hydrogel for medical devices

Semaglutide may lower Alzheimer's risk in type 2 diabetes patients

Semaglutide may lower Alzheimer's risk in type 2 diabetes patients

Arthritis-style immunotherapy shows promise for heart failure

Arthritis-style immunotherapy shows promise for heart failure

New antibody platform targets evolving viruses

New antibody platform targets evolving viruses

Calluna Pharma successfully completes Phase 1 clinical study of CAL101, a first-in-class therapeutic for fibrotic and fibro-inflammatory indications

Calluna Pharma successfully completes Phase 1 clinical study of CAL101, a first-in-class therapeutic for fibrotic and fibro-inflammatory indications

Advancements in antibody-drug conjugates transform cancer therapy

Advancements in antibody-drug conjugates transform cancer therapy

New drug WNTinib shows promise in treating pediatric liver cancer

New drug WNTinib shows promise in treating pediatric liver cancer

Caloric restriction extends mouse lifespan and health in new genetic study

Caloric restriction extends mouse lifespan and health in new genetic study

Elderberry juice boosts fat burning and gut health in overweight adults

Elderberry juice boosts fat burning and gut health in overweight adults

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.